Polychemotherapy regimen

This page covers all Polychemotherapy regimen drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 3 pipeline (6)

• COPPEBVCAD vs BEACOPP vs ABVD · Gruppo Italiano Studio Linfomi · Oncology
  COPPEBVCAD, BEACOPP, and ABVD are combination chemotherapy regimens that use multiple cytotoxic agents to kill rapidly dividing cancer cells.
• BEACOPP escalated · University of Cologne · Oncology
  BEACOPP escalated is a multi-drug chemotherapy regimen that combines bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone at escalated doses to kill rapidly dividing cancer cells.
• HIT-SKK Chemotherapy Cycles B1-3 · Nationwide Children's Hospital · Oncology
  HIT-SKK is a multi-agent chemotherapy regimen combining doxorubicin, cyclophosphamide, etoposide, and other agents designed to treat pediatric hematologic malignancies through DNA damage and cell cycle disruption.
• BEACOPP escalated q3 weeks · European Organisation for Research and Treatment of Cancer - EORTC · Oncology
  BEACOPP escalated is a multi-drug chemotherapy regimen that combines bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone at escalated doses to kill rapidly dividing cancer cells.
• H02+CHOP · Shandong New Time Pharmaceutical Co., LTD · Oncology
  H02+CHOP is a chemotherapy combination regimen that uses doxorubicin, cyclophosphamide, vincristine, and prednisone to inhibit cancer cell proliferation and induce apoptosis.
• BEACOPP regimen · SWOG Cancer Research Network · Oncology
  BEACOPP is a multi-drug chemotherapy regimen that combines bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone to kill rapidly dividing cancer cells through multiple cytotoxic mechanisms.